World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
31974
World Ranking
14931
National Ranking
7547

Overview

Pierre N. Tariot is affiliated with the University of Rochester in the United States. Their research primarily focuses on Medicine, with extensive contributions to Psychiatry and Mental Health, Physiology, Pharmacology, Neurology, and Radiology, Nuclear Medicine and Imaging. Tariot's work extensively covers topics related to dementia, Alzheimer's disease, neurodegenerative diseases, neuroimaging, brain connectivity, and ethics in clinical research.

They have contributed to several frequent publication venues, including:

  • Alzheimer s & Dementia
  • The Journal of Prevention of Alzheimer s Disease
  • Alzheimer s Research & Therapy
  • Neurology
  • JAMA Neurology

Tariot's research topics include:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Cholinesterase and Neurodegenerative Diseases
  • Advanced Neuroimaging Techniques and Applications
  • Functional Brain Connectivity Studies
  • Ethics in Clinical Research
  • Parkinson's Disease Mechanisms and Treatments

Among their recent papers are:

  • "Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study" (2020), published in The Lancet Neurology
  • "Trial of Pimavanserin in Dementia-Related Psychosis" (2021), published in New England Journal of Medicine
  • "The case for low-level BACE1 inhibition for the prevention of Alzheimer disease" (2021), published in Nature Reviews Neurology
  • "Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment" (2022), published in JAMA Neurology
  • "Accelerated functional brain aging in pre-clinical familial Alzheimer's disease" (2021), published in Nature Communications

Frequent collaborators in Tariot's research include:

  • Eric M. Reiman
  • Jessica B. Langbaum
  • Silvia Ríos-Romenets
  • Francisco Lopera
  • Natalia Acosta-Baena

Best Publications

  • Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

    Pierre N. Tariot;Martin R. Farlow;George T. Grossberg;Stephen M. Graham

  • Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

    Lon S. Schneider;Pierre N. Tariot;Karen S. Dagerman;Sonia M. Davis

  • A 5-month, randomized, placebo-controlled trial of galantamine in AD

    Pierre N. Tariot;P. R. Solomon;J. C. Morris;P. Kershaw

  • Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial

    R. Holloway;I. Shoulson;K. Kieburtz;M. McDermott

  • Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

  • Four distinct trajectories of tau deposition identified in Alzheimer’s disease

    Jacob W Vogel;Alexandra L Young;Neil P Oxtoby;Ruben Smith

  • Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease

    Michael F. Egan;James Kost;Pierre N. Tariot;Paul S. Aisen

  • Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study

    Eric M Reiman;Yakeel T Quiroz;Yakeel T Quiroz;Adam S Fleisher;Kewei Chen

  • Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report

    Joseph F. Arboleda-Velasquez;Francisco Lopera;Michael O’Hare;Santiago Delgado-Tirado

  • Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis

    Davis C. Ryman;Natalia Acosta-Baena;Paul S. Aisen;Thomas Bird

  • Efficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia

    Pierre N. Tariot;Rosemary Erb;Carol Ann Podgorski;Christopher Cox

  • The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease

    P N Tariot;J L Mack;M B Patterson;S D Edland

  • Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease

    Michael F. Egan;James Kost;Tiffini Voss;Yuki Mukai

  • Provisional diagnostic criteria for depression of Alzheimer disease.

    Jason T. Olin;Lon S. Schneider;Ira R. Katz;Barnett S. Meyers

  • Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.

    Gerda G. Fillenbaum;Gerda G. Fillenbaum;Gerald van Belle;John C. Morris;Richard C. Mohs

  • A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

    Pierre N. Tariot;Jeffrey L. Cummings;Ira R. Katz;Jacobo Mintzer

  • ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia

    Dilip V Jeste;Dan Blazer;Daniel Casey;Thomas Meeks

  • Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.

    Linda Teri;R. G. Logsdon;E. Peskind;M. Raskind

  • Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease

    E. R. Siemers;J. F. Quinn;J. Kaye;Martin Farlow

  • Intravenous nicotine in Alzheimer's disease: a pilot study

    P. A. Newhouse;T. Sunderland;P. N. Tariot;C. L. Blumhardt

Frequent Co-Authors

Eric M. Reiman
Eric M. Reiman Arizona State University
Francisco Lopera
Francisco Lopera University of Antioquia
Kewei Chen
Kewei Chen Arizona State University
Adam S. Fleisher
Adam S. Fleisher Avid Radiopharmaceuticals
Jeffrey L. Cummings
Jeffrey L. Cummings University of Nevada, Las Vegas
Reisa A. Sperling
Reisa A. Sperling Brigham and Women's Hospital
Lon S. Schneider
Lon S. Schneider University of Southern California
Paul S. Aisen
Paul S. Aisen University of Southern California
Ronald G. Thomas
Ronald G. Thomas University of California, San Diego
Robert M. Cohen
Robert M. Cohen University of Cincinnati Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in healthcare but unsure about committing to a traditional medical degree, there are a range of flexible, affordable online programs worth exploring. These programs can open doors to high-demand fields across the medical sector, offering great career prospects and job stability.

For nurses seeking advanced practice and leadership roles, the best online dnp programs provide a pathway to becoming a Doctor of Nursing Practice while balancing work and study. Pharmacists can accelerate their careers through a 3 year online pharmd, which enables faster entry into the pharmacy profession.

For those interested in the administrative and data side of healthcare, you might consider an online bachelor's in health information management. This degree opens opportunities in medical records management and health IT. Alternatively, a low cost medical coding and billing online program can help you quickly start a career in healthcare administration, often in less than a year.

These online degrees and certifications offer diverse ways to join the growing healthcare industry—without the same time and financial commitments as traditional medical school.

Best Scientists Citing Pierre N. Tariot

Trending Scientists